Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,240,722,841
-
Number of holders
-
1618
-
Total 13F shares, excl. options
-
990,066,372
-
Shares change
-
-6,331,669
-
Total reported value, excl. options
-
$76,108,860,118
-
Value change
-
-$470,860,186
-
Put/Call ratio
-
1.18%
-
Number of buys
-
770
-
Number of sells
-
-841
-
Price
-
$76.94
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q2 2020
1,862 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q2 2020.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,618 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 990,066,372 shares
of 1,240,722,841 outstanding shares and own 79.8% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (125,356,882 shares), BlackRock Inc. (115,834,270 shares), VANGUARD GROUP INC (104,813,339 shares), STATE STREET CORP (58,026,712 shares), Capital International Investors (57,143,147 shares), Capital World Investors (43,503,830 shares), GEODE CAPITAL MANAGEMENT, LLC (19,665,435 shares), Bank of New York Mellon Corp (16,853,680 shares), NORTHERN TRUST CORP (16,081,206 shares), and NORGES BANK (12,927,129 shares).
This table shows the top 1618 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.